Spark, Pfizer pass another milestone with impressive results treating hemophilia B
Spark and its partners at Pfizer have now shown that a group of 10 men treated with their gene therapy for hemophilia B can lead …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
